AbbVie Recalls Lupron Depot-Ped Kits Due to Defective Needle Protection
AbbVie is recalling 12 kits of Lupron Depot-Ped due to a potentially defective needle stick protection device.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of the product may cause temporary or medically reversible health consequences. The defect is in the needle protection device, posing a risk of needle stick injury, but no specific injuries or illnesses are reported in the source text.
Plain-English summary
AbbVie Inc. is recalling 12 kits of LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension), a prescription medication used for 3-month administration. The product is a single-dose administration kit with a prefilled dual-chamber syringe, manufactured for AbbVie Inc. and by Takeda Pharmaceutical Company Limited.
The recall is being issued because some of the kits may contain a syringe with a potentially defective LuproLoc needle stick protection device. The affected product is identified by Lot #1013566 with an expiration date of 12/08/16. The kits were distributed nationwide and in Puerto Rico.
Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above. If the product matches the recalled description, it should be removed from use and returned to the distributor or manufacturer according to standard recall procedures.
The recalled product
- Product
- LUPRON DEPOT-PED (LEUPROLIDE ACETATE)
- Brand
- LUPRON DEPOT-PED
- Manufacturer
- AbbVie Inc
- Category
- Drug — Prescription Injection
- Hazard
- Affected units
- 12
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #:1013566
- Exp 12/08/16
UPCs (1)
- 300743779035
Distribution
Part of a larger recall action
This product is one of 5 recalled by AbbVie Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · AbbVie Inc
See all →- ModeratePred Mild prednisolone eye suspension failed stability specifications
FDA (Drugs) · 2026-06-03
- HighRefresh LACRI-LUBE Eye Ointment Recalled for Potential Tube Seal Breach
FDA (Drugs) · 2024-10-02
- HighFDA Recalls Refresh P.M. Eye Ointment Due to Potential Sterility Breach
FDA (Drugs) · 2024-10-02
- HighSynthroid Levothyroxine Tablets Recalled for Incorrect Barcode Labeling
FDA (Drugs) · 2023-11-15
- LowAbbVie Recalls Ultane Sevoflurane Due to Defective Container Caps
FDA (Drugs) · 2018-02-07
Same hazard · needle stick
See all →- HighBD Cathena IV Catheter Safety Shield May Fail to Properly Engage
FDA (Devices) · 2023-10-11
- HighHaiou Needle Retractable Safety Syringe recalls due to needle detachment risk
FDA (Devices) · 2022-08-17
- HighBone Marrow Aspiration Needle Protector Can Dislodge, Posing Needle-Stick Risk
FDA (Devices) · 2021-10-13
- HighCardinal Health Recalls MONOJECT Hypodermic Needles Due to Detachment Risk
FDA (Devices) · 2020-11-11
- HighGreiner VACUETTE Blood Transfer Units Recalled for Needle Dislodgement Risk
FDA (Devices) · 2020-06-03